Magnesium in acute myocardial infarction [1]

Lancet

Volumn 349, Issue 9047, 1997, Pages 282-283

  Collins, R ^a   Peto, R ^a   Schafer, S ^a   Baxter, G F ^a   Sumeray, M S ^a   Walker, J M ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; MAGNESIUM;

ACUTE HEART INFARCTION; CLINICAL TRIAL; DOG; HEART INFARCTION SIZE; HEART PROTECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; NONHUMAN; PRIORITY JOURNAL; CONTROLLED CLINICAL TRIAL; HEART INFARCTION; MORTALITY; MULTICENTER STUDY; NOTE; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; ANIMAL; METHODOLOGY; PATHOLOGY; SWINE;

HUMANS; MAGNESIUM; MULTICENTER STUDIES; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; RANDOMIZED CONTROLLED TRIALS; ANIMALS; DOGS; RESEARCH DESIGN; SWINE;

EID: 0031031599     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)26004-6     Document Type: Letter

References (15)